john.scarlett@tercica.com
sandra.blethen@tercica.com
george.bright@tercica.com

All,

There is no evidence yet published to suggest that Tercica's product Increlex will benefit any of these conditions: ALS, HIV-AIDS, severe burn, fractured hip, Myotonic Muscular Dystrophy.

PLEASE stop ignoring requests for Iplex, begin distribution immediately and continue to provide the Iplex product to the ALS and other communities who have already experienced positive affects.

Thank you,

Jean B